Fundraising Fox

Coinvest Capital2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Astrolightastrolightspace.cominMay 2025

Astrolight develops laser communication technology for space and defense, including space-to-Earth and space-to-space optical terminals, optical ground stations, and an unjammable radio-silent data link for naval applications.

Deep TechDefense TechSpace Tech

Co-investorsBalnord Sp. z o.o.Seraphim Space

CBRXcbrx.aiinOct 2025

CBRX is a consultancy that designs, tests and governs AI systems for European enterprises, ensuring compliance with EU regulations including GDPR, NIS2, DORA, the EU AI Act and ISO 42001.

AI & Machine LearningCybersecurityEnterprise Software

Kazimieras Sadauskas(Co-founder & CEO)inAudrius Miknevičius(Co-founder & CTO)in

Co-investorsFirstpick

Psylinkpsylink.ioin𝕏Jul 2025

Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.

BiotechDeep TechDigital Health

Co-investorsBSV VenturesFirstpickBSV

Repsenserepsense.ioin𝕏Dec 2025

Repsense builds Havel, an AI-powered narrative intelligence platform that analyzes video and broadcast content to detect coordinated information operations and measure narrative impact.

AI & Machine LearningDefense TechGovTechMarketing TechMedia & EntertainmentVilnius, LT

Mykolas Katkus(CEO & Co-Founder)inAlfredas Chmieliauskas(Chief AI Officer & Co-Founder)Liudvikas Andriulis(Co-Founder & Head of Growth)inAlfredas C(Founder)Dominyka Bernotaitė(Head of Sales)in

Co-investorsBSV VenturesIron Wolf CapitalTensor Ventures

Vugenevugene.cominMay 2025

VUGENE offers an AI/ML-powered multi-omics analysis platform that turns raw biological data—genomics, transcriptomics, proteomics, metabolomics, epigenomics, and single-cell data—into actionable insights on how drugs affect biology.

AI & Machine LearningBiotechHealthtech

Juozas Gordevičius(Founder)in

Co-investorsSuperhero Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.